Background-Pneumococcal infections
are still a major clinical problem. Polymorphonuclear leucocytes (neutrophils) are considered to have a key role in the host's defence against Streptococcus pneumoniae but the mechanisms by which they kill the pneumococcus remain unclear. As reactive oxygen species are regarded as a major antimicrobial defence of phagocytes an attempt has been made to establish their role in the response of neutrophils to S pneumoniae. Methods-S pneumoniae isolated from patients with bacteraemic pneumococcal pneumonia were incubated with neutrophils in suspension and superoxide production was measured by reduction of ferricytochrome c. Results-S pneumoniae did not stimulate superoxide production alone or in the presence of normal human serum. Spontaneous superoxide production by neutrophils was actually abrogated by S pneumoniae, as was the powerfil respiratory burst stimulated by phorbol myristate acetate. This phenomenon depended on both the dose and the viability of the bacteria. With S pneumoniae in the logarithmic phase of growth inhibitory activity was confined to the organisms themselves but with organisms undergoing autolysis it was also present in filtered supernatants, suggesting that the inhibitory activity can be attributed to a factor released during autolysis. Conclusions-S pneumoniae can interfere with the respiratory burst of neutrophils. This property may help to explain the pathogenicity of the organism. (Thorax 1993; 48:364-369) Although penicillin has greatly reduced the number of deaths from pneumococcal infection, Streptococcus pneumoniae remains a major cause of morbidity and mortality. Pneumococcal pneumonia, for example, is the most common form of community acquired pneumonia' and still has an overall mortality of 5-13%,2 though patients who survive almost invariably make a full recovery without detectable lung damage.3 In pneumococcal meningitis the mortality is 30%. 4 Furthermore, the worldwide increase in penicillin resistance and multiple antibiotic resistance among pneumococci5-8 and the limited use of pneumococcal vaccine9 suggest that pneumococcal infection may cause increasing morbidity and mortality in the future.
In the host's defence against S pneumoniae polymorphonuclear leucocytes (neutrophils) are considered to have a key role.
Immunological defences against S pneumoniae include the production of specific anticapsular antibody and activation of complement, both of which function opsonically. [10] [11] [12] Complement is not lytic" and studies with nude mice have indicated that T cells are not necessary for normal host defence.13 These results, and the finding that S pneumoniae is killed by phagocytes in vitro,'4 suggest the primacy of phagocytosis as an effector defence mechanism. The mechanisms by which phagocytes kill the pneumococcus, however, are incompletely understood. These mechanisms are of increasing clinical importance for two main reasons. Firstly, various cytokines, including interferon gamma, tumour necrosis factor, granulocyte-macrophage colony stimulating factor, and interleukin-8, have been shown to enhance the function of neutrophils;"'58 thus the potential now exists for modulating microbial killing by neutrophils. Secondly, the reactive oxygen species that neutrophils produce during microbial killing have been implicated in causing tissue damage,'9 including lung damage,20 which has led to the investigation of a therapeutic role for antioxidants.' If oxidative mechanisms are crucial for killing antioxidants may predispose patients to pneumonia. On the other hand, inhaled microorganisms that stimulate neutrophils to produce large amounts of toxic oxygen species may contribute to lung damage.
Previous studies of microbial killing by phagocytes have indicated the importance of reactive oxygen species. For example, the susceptibility of Toxoplasma gondii and Leishmania donovani promastigotes to killing by phagocytes has been shown to be related to their ability to trigger release of oxygen species2223 and the killing of Escherichia coli, Staphylococcus aureus, and Streptococcus viridans by neutrophils has been shown to be inhibited by scavengers of reactive oxygen species.24 It is not known, however, whether S pneumoniae is killed by reactive oxygen species or whether it stimulates phagocytes to generate an oxidative response. The purpose of the current work was thus to determine whether S pneumoniae stimulates or suppresses the ability of neutrophils to generate superoxide. 0-675 ml 20 mmol/l Na2CO,, 0-1 mmol/l EDTA, 1 mmol/l NaN,; 0 1 ml 50 ,umol/l xanthine; 0-1 ml 5 ,umol/l ferricytochrome c; 0-1 ml superoxide dismutase standard (0-025-1-0 U/ml). Xanthine oxidase 0-025 ml 1 U/ml was added to start the reaction and the reduction of cytochrome c was monitored at 550 nm for five minutes by means of a spectrophotometer linked to a chart recorder. The linear regression was established for the standards. The superoxide dismutase was then substituted with 0 1 ml S pneumoniae suspension (final concentration 15 x 106/ml) or 0-1 ml S pneumoniae culture supematant, Experiments were set up to determine whether the inhibition of phorbol myristate acetate induced superoxide production depended on the dose and viability of the pneumococci. As can be seen from fig 1, the greatest amounts of superoxide were observed in the absence of S pneumoniae (far left). As the concentration of S pneumoniae increased the levels of superoxide detected fell, total inhibition of superoxide production being seen at 15 x 106 ml-'. Figure 2 shows that this inhibitory effect also depends on the viability of S pneumoniae. Viable pneumococci inhibited both phorbol myristate acetate induced and spontaneous superoxide production by neutrophils whereas heat klled S pneumoniae failed to inhibit either at any dose. (fig 3) . As can be seen, inhibition was observed throughout the period studied and was evident at the first time point monitored (5 minutes). The viability (as judged by trypan blue exclusion) of neutrophils incubated with S pneumoniae remained greater than 98%, the same as that of neutrophils incubated alone.
Methods
To determine whether any superoxide dismutase produced by S pneumoniae might interfere with the detection of superoxide anions, the superoxide dismutase activity in S pneumoniae was measured and the effect of this concentration of superoxide dismutase on superoxide production by neutrophils investigated. Both washed S pneumoniae and S pneumoniae supematants each contained less than 0-1 U/ml superoxide dismutase activity. This dose had no effect on spontaneous superoxide detection and reduced phorbol myristate acetate stimulated detection of superoxide by an average of only 8% (n = 3).
The ability of S pneumoniae culture supernatants to exert the inhibitory effect was also investigated (table 2) . Whereas untreated supernatants possessed substantial inhibitory activity, this was lost if the supernatants were either filtered (through a 0-2 ,um bacterial filter) or centrifuged, suggesting that the inhibitory activity of log phase supernatants depends on the presence of viable S pneumoniae within the supematant. Supematants from 18 hour (autolysis phase) cultures were also examined and again showed inhibitory activity (table 2) . In contrast to the log phase of growth, filtering or centrifuging did not remove the activity. S pneumoniae from 18 hour cultures varied widely in their ability to inhibit stimulation of superoxide by phorbol myristate acetate but overall showed less inhibitory activity than log phase organisms.
Experiments were set up to determine whether S pneumoniae can oxidise reduced cytochrome c. The results are presented in table 3. S pneumoniae was able to oxidise reduced cytochrome c but the oxidation did not show the same dose dependency as inhibition of neutrophil superoxide production since all but the lowest concentration of S pneumoniae (1 x 106/ml) oxidised cytochrome c to the same extent. A further difference between the ability of S pneumoniae to oxidise cytochrome c and inhibit superoxide production was that both filtered supernatants from log phase cultures and heat killed organisms retained their ability to oxidise reduced cytochrome c. As it has been reported that hydrogen peroxide (H,O,) can reoxidise cytochrome C29 and H202 is a product of S pneumoniae,0 the effect of the H202 scavenger catalase on the ability of S pneumoniae to oxidise cytochrome c was examined. It was found that 50 tg/ml catalase blocked the reoxidation of cytochrome c by S pneumoniae (table 3) . Experiments were then set up to determine the effect of catalase on the ability of S pneumoniae to inhibit superoxide production by neutrophils ( catalase on reoxidation. Thus whereas catalase blocked reoxidation almost completely it only partially removed the inhibitory effect of S pneumoniae on production of superoxide by neutrophils.
Discussion
These results show that S pneumoniae isolated from patients with bacteraemic pneumococcal pneumonia interferes with the respiratory burst of neutrophils. S pneumoniae appear to inhibit not only the spontaneous production of superoxide by neutrophils but also the strong respiratory burst stimulated by phorbol myristate acetate. The effect was seen with two different serotypes, which are among the major causative organisms of serious pneumococcal infections,29 and depended on both the concentration and the viability of the organisms. It could be argued that S pneumoniae merely kills neutrophils, either rendering them unable to mount a respiratory burst or causing release of neutrophil products that might interfere with the assay. The pneumococci were, however, shown not to affect the viability of the neutrophils.
Another possible explanation for the results was that the S pneumoniae organisms were interfering with the assay by reoxidising cytochrome c. We found that S pneumoniae was capable of oxidising chemically reduced cytochrome c, indicating a pitfall of this method we have not seen discussed elsewhere. Blocking reoxidation did not, however, abrogate the inhibitory effect of S pneumoniae because the organisms retained about 50% (type 1) and over 75% (type 14) of their capacity to inhibit the respiratory burst of neutrophils when reoxidation was blocked by catalase.
Thus S pneumoniae exerts an inhibitory effect on the oxidative response of neutrophils, suggesting that they must either scavenge superoxide or inhibit its production. The production of antioxidant enzymes or scavenging substrates is a recognised defence tactic of microorganisms against phagocytic oxidative activity.'3 Endogenous production of superoxide dismutase and catalase, for example, has been described in many bacterial species and for certain of these, including Staphylococcus aureus, Listeria monocytogenes and Nocardia asteroides, the virulence of different strains correlates with their superoxide dismutase or catalase production."-" We examined the possibility that S pneumoniae produces superoxide dismutase as this could destroy any superoxide produced. Although S pneumoniae samples and supernatants were shown to possess superoxide dismutase activity the amount produced had minimal effect on the respiratory burst of neutrophils.
Whether S pneumoniae possesses other substrates that might scavenge superoxide remains to be elucidated.
The second possibility is that S pneumoniae prevents the generation of reactive oxygen species. Such inhibitory activity has been described for Legionella micdadei,'34 Aspergillus fumigatus,'5 Histoplasma capsulatum,'36 and Yersinia pestis37 and is thought to be associated with their pathogenicity. Inhibition of the respiratory burst of neutrophils is also one of the effects of purified pneumolysin, a toxin produced by S pneumoniae.'5 Experiments were set up to determine whether the inhibitory activity was associated with the pneumococci themselves or with a released factor. Untreated log phase supematants inhibited both spontaneous and neutrophil stimulated superoxide production; treatments that removed any residual bacteria from the supernatant, however, also removed the inhibitory activity. By contrast, the inhibitory activity present in the supernatants of S pneumoniae cultures in the autolysis phase of growth was not removed by filtration or centrifugation, suggesting that it can be attributed to a soluble factor released during autolysis. As pneumolysin is predominantly a product of autolysis phase S pneumoniae,39 and, in purified form, is known to inhibit the respiratory burst of neutrophils, it may be the factor responsible for the inhibitory activity that we have observed. Results to be published elsewhere, however, show that a pneumolysin negative strain of S pneumoniae and its autolysis phase supernatant are also able to inhibit the respiratory burst of neutrophils, showing that pneumococci must produce an inhibitory factor other than pneumolysin.
The ability of S pneumoniae to interfere with the respiratory burst of neutrophils may constitute a major counter defence of the microorganism and help to explain its pathogenicity. Moreover, as toxic oxygen species produced by neutrophils are often implicated in lung damage the inhibitory effect on the respiratory burst may account for the lack of residual lung damage that characterises recovery from pneumococcal pneumonia. Finally, as S pneumoniae can abrogate a powerful respiratory burst it may reduce the capacity of neutrophils to kill other organisms in mixed infections. 
